As of 2024-12-15, the Fair Value of Sorrento Therapeutics Inc (SRNE) is -1,018.24 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.31 USD, the upside of Sorrento Therapeutics Inc is -331,448.85%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -203.50 | -292.10 | -298.50 | -428.30 | -572.80 | -359.04 |
| YoY growth | -2,336.26% | -43.54% | -2.19% | -43.48% | -33.74% | -491.84% |
| Market Cap (mil) | 0.83 |
| P/E | |
| Forward P/E |
| EPS | -203.65 |
| Avg earnings growth rate | -491.84% |
| TTM earnings | -548.00 |